BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 15, 2025
Breaking News: Commission proposes ‘radical overhaul’ of obesity definition, diagnosis
See today's BioWorld Science
Home
» Long Island University and Mount Sinai School of Medicine report KCa3.1 channel blockers for renal disorders
To read the full story,
subscribe
or
sign in
.
Nephrology
Long Island University and Mount Sinai School of Medicine report KCa3.1 channel blockers for renal disorders
April 13, 2023
No Comments
Long Island University and Mount Sinai School of Medicine have jointly developed intermediate conductance KCa3.1 (IKCa1) channel blockers reported to be useful for the treatment of renal disorders.
BioWorld Science
Nephrology
Patents